| %AUC | Percentage area under the curve (chromatogram analysis) |
| AUC | Area under the time–activity curve |
| AUC0–last | Area under the time–activity curve from time zero to the last measurement |
| AUC0–∞ | Area under the time–activity curve, from time zero extrapolated to infinity |
| CT | Computed tomography |
| DFO* | Octadentate derivative of deferoxamine |
| DMSO | Dimethyl sulfoxide |
| DTT | Dithiothreitol |
| FcRn | Neonatal Fc receptor |
| HEPES | 2-(4-(2-hydroxyethyl)piperazin-1-yl)ethanesulfonic acid |
| iTLC | Instant thin-layer chromatography |
| KD | Dissociation equilibrium constant |
| mAb | Monoclonal antibody |
| MSA | Mouse serum albumin |
| NCA | Non-compartmental analysis |
| PBS | Phosphate buffered saline |
| PET | Positron emission tomography |
| pi | Post-injection |
| PK | Pharmacokinetic |
| RCC | Radiochemical conversion |
| RCP | Radiochemical purity |
| SD | Standard deviation |
| SEC | Size-exclusion chromatography |
| SPR | Surface plasmon resonance |
| TAC | Time-activity curve |
| TCEP | Tris(2-carboxyethyl)phosphine |
| TRT | Targeted radionuclide therapy |
| VHH | Variable domain of camelid heavy chain-only antibody |
| VOI | Volume of interest |